Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever
Rosemary Wyber, Ben J Boyd, Samantha Colquhoun, Bart J Currie, Mark Engel, Joseph Kado, Ganesan Karthikeyan, Mark Sullivan, Anita Saxena, Meru Sheel, Andrew Steer, Joseph Mucumbitsi, Liesl Zuhlke, Jonathan Carapetis
Drug Delivery and Translational Research | SPRINGER HEIDELBERG | Published : 2016
Funding from the Telethon New Children's Hospital Research Fund Supported this project. Formulation and drug development advice was kindly provided Medicines Development Limited and the Monash Institute of Pharmaceutical Sciences.